Detection of minimal residual disease.
Gribben
J
J
Tumor Immunology Division, Dana-Farber Cancer Institution, Boston, MA 02115, USA.
Nadler
L
L
D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D002883:Chromosomes, Human, Pair 14; D002887:Chromosomes, Human, Pair 18; D018572:Disease-Free Survival; D016044:Fusion Proteins, bcr-abl / Q000032:analysis / Q000096:biosynthesis; D015321:Gene Rearrangement; D006801:Humans; D018365:Neoplasm, Residual / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology; D009369:Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016133:Polymerase Chain Reaction / Q000379:methods; D011379:Prognosis; D012008:Recurrence; D012680:Sensitivity and Specificity; D014178:Translocation, Genetic
D016044:Fusion Proteins, bcr-abl